Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) Stock Price

SNOAStock

$1.12−72.56%52W

Market Cap$5.36M

P/E—

PEG Ratio1.08

Div yield—

Beta1.32

SNOA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-58.53%

Price vs S&P 500 (4W)-9.07%

PEG Ratio1.08

VGM Score63.72

Book Value / Share (Quarterly)$1.38

P/TBV (Annual)0.29x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)13.75%

Cash Flow / Share (Quarterly)$-0.55

Price vs S&P 500 (YTD)-81.16%

Gross Margin (TTM)38.91%

Net Profit Margin (TTM)-10.33%

EPS (TTM)$-1.22

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-1.22

Revenue Growth (5Y)0.95%

EPS (Annual)$-1.89

ROI (Annual)-95.72%

Gross Margin (Annual)37.97%

Net Profit Margin (5Y Avg)-31.51%

Cash / Share (Quarterly)$1.12

Revenue Growth QoQ (YoY)59.55%

ROA (Last FY)-22.74%

Revenue Growth TTM (YoY)47.00%

EBITD / Share (TTM)$-0.57

ROE (5Y Avg)-76.56%

Operating Margin (TTM)-6.41%

Cash Flow / Share (Annual)$-2.29

P/B Ratio0.81x

P/B Ratio (Quarterly)0.89x

Net Income / Employee (Annual)$-18,900

EV / Revenue (TTM)0.01x

Net Interest Coverage (TTM)-1.36x

ROA (TTM)-15.21%

EPS Incl Extra (Annual)$-1.89

Current Ratio (Annual)2.50x

Quick Ratio (Quarterly)1.56x

3-Month Avg Trading Volume0.12M

52-Week Price Return-72.56%

Revenue / Employee (TTM)$130,500

Tangible BV / Share (Quarterly)$1.10

P/S Ratio (Annual)0.27x

Asset Turnover (Annual)1.40x

52-Week High$4.25

Operating Margin (5Y Avg)-30.16%

EPS Excl Extra (Annual)$-1.89

CapEx CAGR (5Y)1.30%

Tangible BV CAGR (5Y)-12.24%

26-Week Price Return-48.62%

Quick Ratio (Annual)1.64x

13-Week Price Return-7.44%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)2.99x

Enterprise Value$165,000

Revenue / Share Growth (5Y)4.48%

Asset Turnover (TTM)1.47x

Book Value / Share Growth (5Y)-7.71%

Revenue / Employee (Annual)$116,200

Inventory Turnover (Annual)3.69x

Pretax Margin (Annual)-17.51%

Cash / Share (Annual)$1.33

3-Month Return Std Dev58.84%

Gross Margin (5Y Avg)36.46%

Net Income / Employee (TTM)$-13,500

ROE (Last FY)-102.58%

Net Interest Coverage (Annual)-327.00x

EPS Basic Excl Extra (Annual)$-1.89

P/FCF (TTM)5.13x

Receivables Turnover (TTM)7.58x

Total Debt / Equity (Quarterly)0.02x

EPS Incl Extra (TTM)$-1.22

Receivables Turnover (Annual)8.21x

ROI (TTM)-52.27%

P/S Ratio (TTM)0.24x

Pretax Margin (5Y Avg)-31.86%

Revenue / Share (Annual)$11.60

Tangible BV / Share (Annual)$1.62

Price vs S&P 500 (52W)-88.09%

Year-to-Date Return-69.23%

5-Day Price Return-8.94%

EPS Normalized (Annual)$-1.89

ROA (5Y Avg)-27.90%

Net Profit Margin (Annual)-16.26%

Month-to-Date Return-12.50%

Cash Flow / Share (TTM)$-1.37

EBITD / Share (Annual)$-1.38

Operating Margin (Annual)-12.60%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-72.00%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.22

P/TBV (Quarterly)0.41x

P/B Ratio (Annual)1.19x

Inventory Turnover (TTM)3.53x

Pretax Margin (TTM)-11.44%

Book Value / Share (Annual)$1.72

Price vs S&P 500 (13W)-10.12%

Beta1.32x

P/FCF (Annual)6.03x

Revenue / Share (TTM)$5.70

ROE (TTM)-53.56%

52-Week Low$0.85

vGradeA

gGradeB

mGradeD

vgmGradeB

SNOA Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2025	Feb 10, 2026	-$0.29	-$0.48	-65.52%(-$0.19)
Q3 2025	Nov 4, 2025	-$0.31	-$0.32	-3.23%(-$0.01)
Q2 2025	Aug 7, 2025	-$0.51	-$0.76	-49.02%(-$0.25)

SNOA Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.29

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
SNOASonoma Pharmaceuticals, Inc. Common Stock	A	B	D	0.2x	0.9%	38.9%	-6.4%	$1.12
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Sonoma Pharmaceuticals, Inc. Common Stock

Sonoma Pharmaceuticals is a specialty pharmaceutical company focused on medical dermatology, developing therapies for chronic skin conditions including acne, atopic dermatitis, and scarring. Its product portfolio includes Celacyn, Mondoxyne, Alevicyn, Microcyn, and Ceramax Skin Barrier Cream, treating conditions such as scars, itchy skin, and minor irritations. The company generates revenue from product sales in the United States, Latin America, Europe, and Asia.